In blind validation tests, the AI system achieved:
- 75% overall accuracy at the microcalcification-lesion level
- 76% sensitivity for malignant lesions
- 72% accuracy at the breast level
“This solution can be deployed directly on standard radiology workstations,” adds Dr. Yu. “By pre-marking suspicious regions on each mammogram, it enables radiologists to quickly focus on areas of concern, significantly reducing both missed diagnoses and unnecessary biopsies—thereby easing patient discomfort and lowering healthcare costs.”
MEDICA-tradefair.com; Source: Fundamental Research